XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash, cash equivalents and restricted cash $ 1,129,257 $ 1,133,687
Cash, cash equivalents and restricted cash   1,133,537
Short-term marketable debt securities 0 35,097
Accounts receivable, net 84,562 88,783
Inventory, net 62,991 61,948
Prepaid expenses and other current assets, net 31,736 27,741
Total current assets 1,308,546 1,347,106
Property and equipment, net 138,387 145,096
Right-of-use assets, net 151,881 157,616
Intangible assets, net 8,294 8,979
Goodwill 3,290 3,290
Other assets, net 94,200 124,334
Total Assets 1,704,598 1,786,421
Current liabilities:    
Accounts payable 37,603 51,741
Accrued compensation 92,639 72,736
Accrued expenses 67,211 63,475
Deferred revenue 22,556 17,965
Total current liabilities 220,009 205,917
Convertible senior notes, net 1,140,611 1,139,966
Long-term operating lease liabilities 178,907 185,848
Other long-term liabilities 96,786 96,006
Total Liabilities 1,636,313 1,627,737
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2024 and December 31, 2023 0 0
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of March 31, 2024, and December 31, 2023; 121,787,297 and 121,629,861 shares issued and outstanding as of March 31, 2024, and December 31, 2023, respectively 1 1
Additional paid-in capital 2,329,930 2,304,220
Accumulated other comprehensive loss (4,799) (3,675)
Accumulated deficit (2,256,847) (2,141,862)
Total Stockholders’ Equity 68,285 158,684
Total Liabilities and Stockholders’ Equity $ 1,704,598 $ 1,786,421